Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 2601 - 2625 of 3222 in total
A orally active prolyl-hydroxylase inhibitor which can stabilize hypoxia-inducible transcription factor independent of oxygen availability.
Investigational
Marizomib has been used in trials studying the treatment of Cancer, Melanoma, Lymphoma, Glioblastoma, and Malignant Glioma, among others.
Investigational
Etiracetam is under investigation in clinical trial NCT01137110 (Comparison of Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After Subarachnoid Hemorrhage (SAH)).
Investigational
S-3304 has been used in trials studying the treatment of Lung Cancer, Solid Tumors, Non Small Cell Lung Cancer, Stage IIIB Non Small Cell Lung Cancer, and Stage IIIA Non Small Cell Lung Cancer, among others.
Investigational
Procysteine has been used in trials studying the treatment of HIV Infections.
Investigational
MK-8245 has been used in trials studying the treatment of Type 2 Diabetes Mellitus.
Investigational
Prednimustine has been used in trials studying the treatment of Lymphoma.
Investigational
Melengestrol is a steroidal progestin and antineoplastic agent which was never marketed. An acylated derivative, melengestrol acetate, is used as a growth promoter in animals.
Vet approved
Experimental
Experimental
Experimental
Ilomastat is a broad-spectrum matrix metalloproteinase inhibitor.
Experimental
Experimental
Experimental
Investigational
Theanine, a precursor of ethylamine, is found in green tea. It is under investigation in clinical trial NCT00291070 (Effects of L-Theanine in Boys With ADHD).
Investigational
Experimental
Telinavir has been used in trials studying the treatment of HIV Infections.
Investigational
Displaying drugs 2601 - 2625 of 3222 in total